New Deal
Myrtle Potter
CEO at SUMITOVANT BIOPHARMA
Manager
Deal Bio
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Expertise (3)
Key Relationships
Announcement Date
Deal Value
Urovant Sciences
Sumitovant Biopharma
£144m
13 dealmakers
Opentrons Labworks
Khosla Ventures
£146m
7 dealmakers
Myovant Sciences
£1,521m
31 dealmakers